Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
These medications are available as injections or, as of December 2025, in oral pill form for certain FDA-approved products
Some Medicaid programs may cover tirzepatide
Phase 2 trial results (48 weeks, adults with obesity): 1 mg dose: 7.2% body weight loss 4 mg dose: 12.9% body weight loss 8 mg dose: 17.3% body weight loss 12 mg dose: 24.2% body weight loss Placebo: 1.6% body weight loss Phase 3 TRIUMPH-4 results: 9 mg dose: 20.0% body weight loss (22.9 kg / 50.5 lbs) 12 mg dose: 23.7% body weight loss (27.2 kg / 60.0 lbs) Placebo: 4.6% body weight loss In a separate phase 3 analysis, retatrutide at the highest dose achieved up to 28.7% weight loss
Partially hydrolysed guar gum (PHGG) has emerged as a particularly promising prebiotic in SIBO management, with research demonstrating its ability to enhance antibiotic efficacy
In particular, agonism of FGFR1c appears essential to mediating FGF21s suppression of fatty acid flux from adipose tissue to liver
